Removing the Hidden Data Dependency of DIA with Predicted Spectral Libraries.


Journal

Proteomics
ISSN: 1615-9861
Titre abrégé: Proteomics
Pays: Germany
ID NLM: 101092707

Informations de publication

Date de publication:
02 2020
Historique:
received: 19 09 2019
revised: 20 12 2019
pubmed: 26 1 2020
medline: 22 12 2020
entrez: 26 1 2020
Statut: ppublish

Résumé

Data-independent acquisition (DIA) generates comprehensive yet complex mass spectrometric data, which imposes the use of data-dependent acquisition (DDA) libraries for deep peptide-centric detection. Here, it is shown that DIA can be redeemed from this dependency by combining predicted fragment intensities and retention times with narrow window DIA. This eliminates variation in library building and omits stochastic sampling, finally making the DIA workflow fully deterministic. Especially for clinical proteomics, this has the potential to facilitate inter-laboratory comparison.

Identifiants

pubmed: 31981311
doi: 10.1002/pmic.201900306
doi:

Substances chimiques

Peptide Library 0
Peptides 0
Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1900306

Informations de copyright

© 2020 The Authors. Proteomics published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

Y. S. Ting, J. D. Egertson, S. H. Payne, S. Kim, B. MacLean, L. Kall, R. Aebersold, R. D. Smith, W. S. Noble, M. J. MacCoss, Mol Cell Proteomics. 2015, 14(9), 2301.
C. Ludwig, L. Gillet, G. Rosenberger, S. Amon, B. C. Collins, R. Aebersold, Mol. Syst. Biol. 2018, 8, 8126.
L. Reiter, O. Rinner, P. Picotti, R. Huttenhain, M. Beck, M. Y. Brusniak, M. O. Hengartner, R. Aebersold, Nat. Methods 2011, 8, 430.
L. Kall, J. D. Canterbury, J. Weston, W. S. Noble, M. J. MacCoss, Nat. Methods 2007, 4, 923.
J. Teleman, H. L. Röst, G. Rosenberger, U. Schmitt, L. Malmström, J. Malmström, F. Levander, Bioinformatics 2015, 31, 555.
E. Govaert, K. Van Steendam, S. Willems, L. Vossaert, M. Dhaenens, D. Deforce, Proteomics 2017, 17, 1700052.
R. Gabriels, L. Martens, S. Degroeve, Nucleic Acids Res. 2019, 47, W295.
S. Gessulat, T. Schmidt, D. P. Zolg, P. Samaras, K. Schnatbaum, J. Zerweck, T. Knaute, J. Rechenberger, B. Delanghe, A. Huhmer, U. Reimer, H.-C. Ehrlich, S. Aiche, B. Kuster, M. Wilhelm, Nat. Methods 2019, 16, 509.
S. Tiwary, R. Levy, P. Gutenbrunner, F. Salinas Soto, K. K. Palaniappan, L. Deming, M. Berndl, A. Brant, P. Cimermancic, J. Cox, Nat. Methods 2019, 16, 519.
B. C. Searle, L. K. Pino, J. D. Egertson, Y. S. Ting, R. T. Lawrence, B. X. MacLean, J. Villén, M. J. MacCoss, Nat. Commun. 2018, 9, 5128.
G. Rosenberger, I. Bludau, U. Schmitt, M. Heusel, C. L. Hunter, Y. Liu, M. J. MacCoss, B. X. MacLean, A. I. Nesvizhskii, P. G. A. Pedrioli, L. Reiter, H. L. Rost, S. Tate, Y. S. Ting, B. C. Collins, R. Aebersold, Nat. Methods 2017, 14, 921.
G. Rosenberger, C. C. Koh, T. Guo, H. L. Röst, P. Kouvonen, B. C. Collins, M. Heusel, Y. Liu, E. Caron, A. Vichalkovski, M. Faini, O. T. Schubert, P. Faridi, H. A. Ebhardt, M. Matondo, H. Lam, S. L. Bader, D. S. Campbell, E. W. Deutsch, R. L. Moritz, S. Tate, R. Aebersold, Sci. Data 2014, 1, 140031.
Y. S. Ting, J. D. Egertson, J. G. Bollinger, B. C. Searle, S. H. Payne, W. S. Noble, M. J. MacCoss, Nat. Methods 2017, 14, 903.
N. Colaert, S. Degroeve, K. Helsens, L. Martens, J. Proteome Res. 2011, 10, 5555.
L. Moruz, A. Staes, J. M. Foster, M. Hatzou, E. Timmerman, L. Martens, L. Kall, Proteomics 2012, 12, 1151.
A. Panchaud, A. Scherl, S. A. Shaffer, P. D. Von Haller, H. D. Kulasekara, S. I. Miller, D. R. Goodlett, Anal. Chem. 2009, 81, 6481.
M. Vaudel, J. M. Burkhart, D. Breiter, R. P. Zahedi, A. Sickmann, L. Martens, J. Proteome Res. 2012, 11, 5065.
B. C. Searle, K. E. Swearingen, C. A. Barnes, T. Schmidt, S. Gessulat, B. Kuster, M. Wilhelm, bioRxiv 2019, 682245.
V. Demichev, C. B. Messner, S. I. Vernardis, K. S. Lilley, M. Ralser, Nature Methods 2020, 17, 41.
S. Willems, S. Daled, B. Van Puyvelde, L. De Clerck, S. Vande Casteele, F. Van Nieuwerburgh, D. Deforce, M. Dhaenens, bioRxiv 2019, https://doi.org/10.1101/726273.

Auteurs

Bart Van Puyvelde (B)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000, Ghent, Belgium.

Sander Willems (S)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000, Ghent, Belgium.

Ralf Gabriels (R)

VIB-UGent Center for Medical Biotechnology, 9000, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, 9000, Ghent, Belgium.

Simon Daled (S)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000, Ghent, Belgium.

Laura De Clerck (L)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000, Ghent, Belgium.

Sofie Vande Casteele (S)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000, Ghent, Belgium.

An Staes (A)

VIB-UGent Center for Medical Biotechnology, 9000, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, 9000, Ghent, Belgium.
VIB Proteomics Core, 9000, Ghent, Belgium.

Francis Impens (F)

VIB-UGent Center for Medical Biotechnology, 9000, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, 9000, Ghent, Belgium.
VIB Proteomics Core, 9000, Ghent, Belgium.

Dieter Deforce (D)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000, Ghent, Belgium.

Lennart Martens (L)

VIB-UGent Center for Medical Biotechnology, 9000, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, 9000, Ghent, Belgium.

Sven Degroeve (S)

VIB-UGent Center for Medical Biotechnology, 9000, Ghent, Belgium.
Department of Biomolecular Medicine, Ghent University, 9000, Ghent, Belgium.

Maarten Dhaenens (M)

ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, 9000, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH